Middle East Pharmaceutical Industries Company
NYSE
Middle East Pharmaceutical Industries Company's latest marketcap:
As of 06/09/2025, Middle East Pharmaceutical Industries Company's market capitalization has reached $654.66 M. According to our data, Middle East Pharmaceutical Industries Company is the 11988th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 654.66 M |
| Revenue (ttm) | 110.58 M |
| Net Income (ttm) | 23.92 M |
| Shares Out | 20 M |
| EPS (ttm) | 1.2 |
| Forward PE | 25.44 |
| Ex-Dividend Date | 05/04/2025 |
| Earnings Date | 08/12/2025 |
Middle East Pharmaceutical Industries Company's yearly market capitalization.
| Date | Market Cap(SAR) | Change (%) |
|---|---|---|
| 06/09/2025 | 2.46 B | 0.99% |
| 12/31/2024 | 2.44 B |
Company Profile
About Middle East Pharmaceutical Industries Company
Middle East Pharmaceutical Industries Company is a leading player in the research, development, manufacturing, and marketing of generic medicines and pharmaceutical preparations. Operating in Saudi Arabia and internationally, the company serves diverse healthcare needs through its innovative product portfolio.
Business Segments
The company operates through three key segments:
- Private: Focused on consumer healthcare products.
- Public: Supplies medicines to government and institutional clients.
- Export: Expands market reach beyond Saudi Arabia.
Product Offerings
Middle East Pharmaceutical Industries provides a wide range of pharmaceutical and healthcare solutions, including:
- Medicines for skin diseases, respiratory conditions, and CNS disorders.
- Digestive, musculoskeletal, urinary, and reproductive system drugs.
- Disinfectants, antiseptics, and anti-infective treatments.
- Specialized products for diabetes, cardiovascular health, and pain relief.
- Cosmetic and nutritional supplements.
Products are available in various forms such as creams, syrups, capsules, gels, and tablets.
Additional Services
Beyond its core business, the company offers:
- Contract manufacturing for pharmaceutical products.
- Export of medicines to international markets.
Company Background
Originally established in 1998 as Middle East Chemical Products Factory Company, the firm rebranded to its current name in January 2006. Headquartered in Riyadh, Saudi Arabia, the company continues to expand its presence in the global pharmaceutical industry.
Frequently Asked Questions
-
What is Middle East Pharmaceutical Industries Company's (TADAWUL-4016) current market cap?As of 06/09/2025, Middle East Pharmaceutical Industries Company (including the parent company, if applicable) has an estimated market capitalization of $654.66 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Middle East Pharmaceutical Industries Company (TADAWUL-4016) rank globally by market cap?Middle East Pharmaceutical Industries Company global market capitalization ranking is approximately 11988 as of 06/09/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.